5 Scleroderma Clinical Trials in Boston, NY (2026)

Q: How do I join a clinical trial in Boston?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Boston research site will contact you.

Recruiting Scleroderma Studies in Boston

NCT06195072Recruiting

Platform Clinical Study for Conquering Scleroderma

The goal of this clinical trial is to test efficacy of different investigational products (IPs) compared with placebo on the change from baseline to the end of the treatment period at Week 52 in lung ...

Boston, NY400 participantsScleroderma Research Foundation, Inc.

View Study Details

NCT06655896Recruiting

Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cutaneous Systemic Sclerosis

The purpose of this study is to evaluate the efficacy, safety and tolerability of rapcabtagene autoleucel (administered once following lymphodepletion) in participants with severe refractory diffuse c...

Boston, NY96 participantsNovartis Pharmaceuticals

View Study Details

NCT07287670Recruiting

EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)

A Phase 2 Randomized, Double-blind, Placebo-Controlled Study of the Safety and Efficacy of MTX-474 in Participants with Diffuse Cutaneous Systemic Sclerosis (dcSSc)...

Boston, NY85 participantsMediar Therapeutics

View Study Details

NCT06843239Recruiting

Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE)

The study is a Phase 2, multi-center, randomized, double-blind, placebo-controlled study to evaluate the effects of tibulizumab over 24 weeks (Period 1) in adult participants with systemic sclerosis, ...

Boston, NY80 participantsZura Bio Inc

View Study Details

NCT07090226Recruiting

Diffuse Cutaneous Scleroderma (DSSc) SFDI Study

Scleroderma (SSc) is an autoimmune disease characterized by fibrosis (or collagen deposition) of the skin and internal organs. The extent of skin fibrosis is an important predictor of internal organ c...

Boston, NY65 participantsBoston University

View Study Details

About Scleroderma Clinical Trials in Boston

Scleroderma is an autoimmune connective tissue disease characterized by hardening and tightening of the skin and connective tissues. Systemic sclerosis can also affect internal organs including lungs, kidneys, and heart. Treatment is directed at specific symptoms and organ involvement.

There are currently 5 scleroderma clinical trials recruiting participants in Boston, NY. These studies are seeking a combined 726 participants. Research is being sponsored by Scleroderma Research Foundation, Inc., Novartis Pharmaceuticals, Mediar Therapeutics and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Scleroderma Clinical Trials in Boston — FAQ

Are there scleroderma clinical trials in Boston?

Yes, there are 5 scleroderma clinical trials currently recruiting in Boston, NY. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Boston?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Boston research site will contact you about next steps.

Are clinical trials in Boston free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Boston studies also compensate for your time and travel.

What scleroderma treatments are being tested?

The 5 active trials in Boston are testing new therapies including novel drugs, biologics, and treatment approaches for scleroderma.

Data updated July 13, 2026 from ClinicalTrials.gov